EXAS vs POST · rev $2.76B vs P/E 15, rev $8.16B
EXACT Sciences Corporation (EXAS) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
EXAS currently screens at market cap $20.03B. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the EXAS and POST stock pages for the full models.
Not investment advice.